Matthew Guo
Impact in
- Nephrology top 0.5%
- Parathyroid Disorders and Treatments
-
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Hematology 16
- Platelet Disorders and Treatments 10
- Blood groups and transfusion 5
- Hematopoietic Stem Cell Transplantation 4
- Oncology 15
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Sucha O. Asbell (1 shared paper)Jonathan J. Beitler (1 shared paper)John S. Macdonald (1 shared paper)Jay S. Cooper (1 shared paper)Lawrence Leichman (1 shared paper)Sharon A. Spencer (1 shared paper)Anthony H. Russell (1 shared paper)Mary V. Graham (1 shared paper)
- Journals
- Journal of Clinical Oncology (14 papers)Blood (13 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)Journal of the American Society of Nephrology (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Matthew Guo
45 papers receiving 4.7k citations
Matthew Guo's Hit Papers
Peers
Comparison fields: 5 of 104
- Nephrology 961
- Pulmonary and Respiratory Medicine 1.5k
- Hematology 513
- Oncology 1.2k
- Surgery 1.5k
Countries citing papers authored by Matthew Guo
This map shows the geographic impact of Matthew Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Guo more than expected).
Fields of papers citing papers by Matthew Guo
This network shows the impact of papers produced by Matthew Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Guo. The network helps show where Matthew Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemoradiotherapy of Locally Advanced Esophageal Cancer Hit paper breakdown → | 1999 | 1532 |
| 2 | Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial Hit paper breakdown → | 2016 | 561 |
| 3 | Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2019 | 368 |
| 4 | 2005 | 359 | |
| 5 | 2008 | 336 | |
| 6 | 2005 | 335 | |
| 7 | 2003 | 201 | |
| 8 | 2017 | 140 | |
| 9 | 2017 | 133 | |
| 10 | 2005 | 116 | |
| 11 | 2008 | 115 | |
| 12 | 1998 | 92 | |
| 13 | 2018 | 84 | |
| 14 | 1999 | 81 | |
| 15 | 2018 | 71 | |
| 16 | 2005 | 46 | |
| 17 | 2018 | 37 | |
| 18 | 2017 | 33 | |
| 19 | 2010 | 29 | |
| 20 | 2018 | 29 |
About Matthew Guo
Matthew Guo is a scholar working on Hematology, Oncology, Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 45 papers that have together received 4.9k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (10 papers), Blood groups and transfusion (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Parathyroid Disorders and Treatments (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Sarcoma Diagnosis and Treatment (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Autoimmune Bullous Skin Diseases (3 papers). The work is most often cited by research in Nephrology (961 citations), Pulmonary and Respiratory Medicine (1.5k citations), Hematology (513 citations), Oncology (1.2k citations) and Surgery (1.5k citations). Matthew Guo has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Sucha O. Asbell, Jonathan J. Beitler, John S. Macdonald, Jay S. Cooper, Lawrence Leichman, Sharon A. Spencer, Anthony H. Russell, Mary V. Graham, James A. Martenson and Muhyi Al‐Sarraf. Their work appears in journals such as Journal of Clinical Oncology, Blood, The Journal of Clinical Endocrinology & Metabolism, Journal of the American Society of Nephrology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.